- 教师名称：穆昕
- 教师拼音名称：Mu Xin
- 出生日期：1982-11-26
- 性别：男
- 职务：副院长
- 职称：副教授
-
Paget, M., Cadena, C., Ahmad, S., Wang, H. T., Jordan, T. X., Kim, E., Koo, B., Lyons, S. M., Ivanov, P., tenOever, B., Mu, X., & Hur, S*. (2023). Stress granules are shock absorbers that prevent excessive innate immune responses to dsRNA. Molecular cell, 83(7), 1180–1196.e8. https://doi.org/10.1016/j.molcel.2023.03.010
-
Li, X., Sun, X., Yan, Z., Zhao, Z., Pang, Z., Yang, H., Ji, X., Lei, Y., Zhu, Z.*, Guo, X.*, & Mu, X*. (2023). New role of gramicidin A in RIG-I-like receptors-mediated IFN signalling. Immunology, 169(2), 219–228. https://doi.org/10.1111/imm.13626
-
Zhang, Q., Yang, Y., Lan, J., Wang, Z., Gao, Y., Li, X., Mao, W., Xie, J., Mi, L. Z., Zhang, X., Wang, X., Mu, X.*, & Mei, K*. (2023). Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD. Frontiers in immunology, 14, 1259386. https://doi.org/10.3389/fimmu.2023.1259386
-
Wang, Z., Li, F., Feng, C., Zheng, D., Pang, Z., Ma, Y., Xu, Y., Yang, C., Li, X., Peng, S.*, Liu, Z.*, & Mu, X*. (2024). 1-Naphthaleneacetic Acid Improved the In Vitro Cell Culturing by Inhibiting Apoptosis. Advanced biology, 8(3), e2300593. https://doi.org/10.1002/adbi.202300593
-
Liu, J., Liu, L., Zeng, S., Meng, X., Lei, N., Yang, H., Li, R., Mu, X.*, & Guo, X*. (2024). Inhibition of EV71 replication by an interferon-stimulated gene product L3HYPDH. Virus research, 342, 199336. https://doi.org/10.1016/j.virusres.2024.199336
-
Li, F., Wang, Z., Zheng, D., Pang, Z., Feng, C., Ma, Y., Yang, C., Li, X., Peng, S.*, Liu, Z.*, & Mu, X*. (2024). NK92 cells and peripheral blood NK cells respond oppositely upon dasatinib treatment. Immunology, 172(1), 163–177. https://doi.org/10.1111/imm.13768
-
Jiang, N., Yang, H., Lei, Y., Qin, W., Xiong, H., Chen, K., Mei, K., Li, G., Mu, X.*, & Chen, R.* (2025). Characterization of dsRNA binding proteins through solubility analysis identifies ZNF385A as a dsRNA homeostasis regulator. Nature communications, 16(1), 3433. https://doi.org/10.1038/s41467-025-58704-7
-
Li, P., Li, F., Hou, X., Li, X., Mu, X.*, Liu, H.*, & Peng, S*. (2025). Immunotherapy for Lung Cancer. Progress in Biochemistry and Biophysics, 52(8), 1998-2017. https://doi.org/10.16476/j.pibb.2025.0038
-
Pang, Z., Yang, H., Li, B., Liu, Y., Zhao, Z., Zhu, Z., Peng, S.*, Mu, X.*, & Yu, H*. (2025). Screening and Validation of Negative Regulators of the Type I Interferon Pathway. Advanced biology, 9(11), e00736. https://doi.org/10.1002/adbi.202400736
-
Liu, Y., Zhao, Z., Ji, X., Lei, Y., Zheng, D., Huang, Y., An, J., Gao, C., Wang, Z., Si, Y., Chen, X., Li, X., Peng, S., Yu, H., Liu, Z.*, Zhu, Z.*, & Mu, X*. (2026). HSPA6 is induced by RIG-I-like receptors and negatively regulates type-I interferon signaling. Cellular and molecular life sciences : CMLS, 83(1), 137. https://doi.org/10.1007/s00018-026-06147-8
-
Zheng, D., Li, F., Zhang, Z., Dong, Y., Zhang, X., Li, X., Yang, J., Peng, S.*, Chen, B.*, Sun, S.*, Liu, Z.*, & Mu, X*. (2026). TFPI2 promotes NK cell-mediated glioblastoma killing through adhesion and checkpoint control. Proceedings of the National Academy of Sciences of the United States of America, 123(25), e2529973123. https://doi.org/10.1073/pnas.2529973123
